L522-0699 Screening compound: 4'-(benzylsulfamoyl)-N-[(4-chlorophenyl)methyl]-[1,1'-biphenyl]-4-carboxamide

L522-0699 Screening compound: 4'-(benzylsulfamoyl)-N-[(4-chlorophenyl)methyl]-[1,1'-biphenyl]-4-carboxamide
L522-0699 Screening compound: 4'-(benzylsulfamoyl)-N-[(4-chlorophenyl)methyl]-[1,1'-biphenyl]-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L522-0699
4'-(benzylsulfamoyl)-N-[(4-chlorophenyl)methyl]-[1,1'-biphenyl]-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L522-0699

Molecular Formula

C27H23ClN2O3S (C27 H23 ClN2 O3 S)

Compound Name

4'-(benzylsulfamoyl)-N-[(4-chlorophenyl)methyl]-[1,1'-biphenyl]-4-carboxamide

IUPAC name

4'-(benzylsulfamoyl)-N-[(4-chlorophenyl)methyl]-[11'-biphenyl]-4-carboxamide

SMILES

O=C(c(cc1)ccc1-c(cc1)ccc1S(NCc1ccccc1)(=O)=O)NCc(cc1)ccc1Cl

InChI

InChI=1S/C27H23ClN2O3S/c28-25-14-6-21(7-15-25)18-29-27(31)24-10-8-22(9-11-24)23-12-16-26(17-13-23)34(32,33)30-19-20-4-2-1-3-5-20/h1-17,30H,18-19H2,(H,29,31)

InChI Key

TWGRAJXLZKYNLS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15129368

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

491.01

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

5.810

Distribution Coefficient, logD

5.809

Water Solubility, LogSw

-6.13

Polar Surface Area

66.138

Acid Dissociation Constant (pKa)

10.66

Base Dissociation Constant (pKb)

-5.49

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

7.40

L522-0699 in Drug Discovery

Included in Screening Libraries

Glucocorticoid receptors Library (4806 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
  • Endocrine
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Nuclear receptors
  • Phosphatases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L522-0699 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L522-0699?
Check Price and Availability of L522-0699, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L522-0699 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L522-0699
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L522-0699
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L522-0699 available by request